JAGX

Jaguar Health, Inc. is a commercial-stage pharmaceuticals company focused on developing plant-based prescription medicines for gastrointestinal distress. The company markets Mytesi, a prescription medicine for the symptomatic relief of diarrhea in adults living with HIV/AIDS on antiretroviral therapy. Jaguar is also developing Crofelemer for additional indications including cancer therapy-related diarrhea and congenital diarrheal disorders. The company leverages sustainable botanical ingredients from South American rainforests in its drug development efforts.